Tehran University of Medical Sciences Acta Medica Iranica 0044-6025 58 1 2020 06 16 27 31 Hossein Yahyazadeh Clinical Cancer Research Center, Milad General Hospital, Tehran, Iran Marzieh Beheshti Clinical Cancer Research Center, Iran University of Medical Sciences, Tehran, Iran. Azita Abdollahinejad Clinical Cancer Research Center, Milad General Hospital, Tehran, Iran. Maria Hashemian Clinical Cancer Research Center, Milad General Hospital, Tehran, Iran. Narges Sistany Allahabadi Clinical Cancer Research Center, Milad General Hospital, Tehran, Iran. Sahel Valadan Tahbaz Clinical Cancer Research Center, Milad General Hospital, Tehran, Iran. 2019 07 12 2020 04 25 Breast cancer is the most prevalent Iranian female malignancy. Breast screening reduces the number of malignant breast diseases. We aimed to assess the results of the pilot breast cancer screening on early detection in female medical staff in Milad Hospital, Tehran, Iran. A cross-sectional study. Female medical staff from Milad Hospital, Tehran, Iran, were examined by a specialist in 2016. A checklist, including demographic data, was completed by the participants. If necessary, they referred to as sonography or mammography. Data were analyzed using SPSS software. Of 746 people enrolled, 137 had no pathological point, 609 had suspicious or positive findings that were referred for further investigation, 449 had normal findings, and 7 had suspicious mass and were biopsied, 6 were benign. One case had primary invasive cancer. Since screening for breast cancer helps to early detection of this disease, the implementation of cancer screening programs should be on the priority of health authorities. https://acta.tums.ac.ir/index.php/acta/article/view/7990 https://acta.tums.ac.ir/index.php/acta/article/download/7990/5364